STOCK TITAN

UnitedHealth EVP Granted 28,414 Stock Options

UnitedHealth Group executive Christopher R. Zaetta received new equity awards, including 28,414 non-qualified stock options with a $282.34 per-share exercise price expiring on February 23, 2036, and a grant of 7,084 shares of common stock.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UnitedHealth Group executive Christopher R. Zaetta received new equity awards, including 28,414 non-qualified stock options with a $282.34 per-share exercise price expiring on February 23, 2036, and a grant of 7,084 shares of common stock. On the same date, 129.454 common shares were delivered to cover tax liabilities. Following these transactions, he directly holds 16,626.54 shares of UnitedHealth common stock. Footnotes state that restricted stock units and the non-qualified options vest 25% annually each February 23 from 2027 through 2030.

Positive

  • None.

Negative

  • None.
Insider Zaetta Christopher R
Role EVP & Chief Legal Officer
Type Security Shares Price Value
Grant/Award Non-Qualified Stock Options (right to buy) 28,414 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 129.454 $282.34 $37K
Grant/Award Common Stock 7,084 $0.00 $0.00
Holdings After Transaction: Non-Qualified Stock Options (right to buy) — 28,414 contracts (Direct); Common Stock — 16,626.54 shares (Direct)
Footnotes (2)
  1. F1. The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030.
  2. F2. The non-qualified stock options vest at a rate of 25% annually on February 23 from the years 2027 through 2030.
Non-qualified stock options granted 28,414 shares Grant of non-qualified stock options on 2026-02-23
Option exercise price $282.34 per share Exercise price for non-qualified stock options granted
Option expiration date 2036-02-23 Expiration date of non-qualified stock options
Common stock grant 7,084 shares Grant of common stock on 2026-02-23
Shares delivered for taxes 129.454 shares Common stock used to satisfy tax liability on 2026-02-23
Post-transaction common stock holding 16,626.54 shares Direct UnitedHealth common stock held after transactions
Equity vesting schedule 25% annually 2027-2030 Vesting for restricted stock units and non-qualified options
Non-Qualified Stock Options (right to buy) financial
"security_title "Non-Qualified Stock Options (right to buy)" with a $282.34 exercise price"
restricted stock units financial
"Footnote: "The restricted stock units vest at a rate of 25% annually""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action "tax-withholding disposition" for 129.454 common shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
non-derivative financial
"transaction_type "non-derivative" for common stock entries"
derivative financial
"transaction_type "derivative" for the non-qualified stock options grant"
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did UNH executive Christopher R. Zaetta receive in this Form 4?

Christopher R. Zaetta received 28,414 non-qualified stock options at a $282.34 exercise price and a separate grant of 7,084 shares of common stock, reflecting UnitedHealth Group’s equity-based executive compensation structure.

How many UnitedHealth Group (UNH) shares did Zaetta have withheld for taxes?

Zaetta had 129.454 shares of common stock delivered to cover tax liabilities at $282.34 per share. This tax-withholding disposition reduced his gross award but is part of standard treatment of equity compensation for executives.

What is Christopher R. Zaetta’s post-transaction common stock holding in UNH?

After the reported transactions, Zaetta directly holds 16,626.54 shares of UnitedHealth common stock. This figure reflects his remaining ownership position following new grants and the small tax-withholding share delivery on February 23, 2026.

What are the vesting terms for Zaetta’s UnitedHealth equity awards?

Footnotes state that restricted stock units and non-qualified stock options vest at a rate of 25% annually on February 23 in each year from 2027 through 2030, creating a four-year, time-based vesting schedule.

What is the expiration date and exercise price of Zaetta’s UNH stock options?

Zaetta’s non-qualified stock options have a $282.34 per-share exercise price and expire on February 23, 2036. These options provide long-term potential value tied to UnitedHealth Group’s future stock performance over a 10-year term.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zaetta Christopher R

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/23/2026 F 129.454 D $282.34 9,542.54 D
Common Stock 02/23/2026 A 7,084(1) A $0 16,626.54 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options (right to buy) $282.34 02/23/2026 A 28,414 (2) 02/23/2036 Common Stock 28,414 $0 28,414 D
Explanation of Responses:
1. The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030.
2. The non-qualified stock options vest at a rate of 25% annually on February 23 from the years 2027 through 2030.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta 02/25/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading